Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-23

Clinical Trial Update: Cinnamon and Ginger in Comparison to Chlorhexidine Gluconate 0.2% on Oral Streptococcus Mutans [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing cinnamon and ginger to chlorhexidine gluconate 0.2% for reducing oral Streptococcus mutans in dental caries; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine Gluconate 0.2% (Chlorhexidine gluconate)
  • Cinnamon (cinnamon)
  • Ginger (Zingiber officinale)

Snippet

Sponsor: Cairo University | Conditions: Dental Caries | Phase 3 | Status: UNKNOWN